APO RESEARCH · REPORT
Functional Dyspepsia Drug
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
Product & engineering
Understand the product.
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
Selected research
Industry Research
Functional Dyspepsia Drug Industry Research Report 2026
Market perspective
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
Report Scope
Read the full market overview
This report quantifies the global Functional Dyspepsia Drug market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Functional Dyspepsia Drug Market by Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Functional Dyspepsia Drug Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Functional Dyspepsia Drug Segment by Application
Hospitals
Drugstores
Functional Dyspepsia Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Dyspepsia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Functional Dyspepsia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Dyspepsia Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Functional Dyspepsia Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Functional Dyspepsia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prokinetic Drugs
- Gastric Antisecretory Drugs
- Others
Applications
- Hospitals
- Drugstores
Companies covered
- Bayer
- Sumitomo
- Cadila Pharmaceuticals
- Teva
- Johnson & Johnson
- Pfizer
- Sanofi
- AstraZeneca
- Jiangsu Aosaikang Pharma
- Eisai
- Kyowa Kirin Pharmaceuticals
- Hanmi Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Functional Dyspepsia Drug Market Size (2021-2032)
- 2.2.2 Global Functional Dyspepsia Drug Sales (2021-2032)
- 2.2.3 Global Functional Dyspepsia Drug Market Average Price (2021-2032)
- 2.3 Functional Dyspepsia Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Prokinetic Drugs
- 2.3.3 Gastric Antisecretory Drugs
- 2.3.4 Others
- 2.4 Functional Dyspepsia Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Drugstores
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Functional Dyspepsia Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Functional Dyspepsia Drug Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Functional Dyspepsia Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Functional Dyspepsia Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Functional Dyspepsia Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Functional Dyspepsia Drug, Product Type & Application
- 3.8 Global Manufacturers of Functional Dyspepsia Drug, Established Date
- 3.9 Global Functional Dyspepsia Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer
- 4.1.1 Bayer Company Information
- 4.1.2 Bayer Business Overview
- 4.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
- 4.1.5 Bayer Recent Developments
- 4.2 Sumitomo
- 4.2.1 Sumitomo Company Information
- 4.2.2 Sumitomo Business Overview
- 4.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
- 4.2.5 Sumitomo Recent Developments
- 4.3 Cadila Pharmaceuticals
- 4.3.1 Cadila Pharmaceuticals Company Information
- 4.3.2 Cadila Pharmaceuticals Business Overview
- 4.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
- 4.3.5 Cadila Pharmaceuticals Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Functional Dyspepsia Drug Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 Johnson & Johnson
- 4.5.1 Johnson & Johnson Company Information
- 4.5.2 Johnson & Johnson Business Overview
- 4.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
- 4.5.5 Johnson & Johnson Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Sanofi
- 4.7.1 Sanofi Company Information
- 4.7.2 Sanofi Business Overview
- 4.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi Functional Dyspepsia Drug Product Portfolio
- 4.7.5 Sanofi Recent Developments
- 4.8 AstraZeneca
- 4.8.1 AstraZeneca Company Information
- 4.8.2 AstraZeneca Business Overview
- 4.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
- 4.8.5 AstraZeneca Recent Developments
- 4.9 Jiangsu Aosaikang Pharma
- 4.9.1 Jiangsu Aosaikang Pharma Company Information
- 4.9.2 Jiangsu Aosaikang Pharma Business Overview
- 4.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
- 4.9.5 Jiangsu Aosaikang Pharma Recent Developments
- 4.10 Eisai
- 4.10.1 Eisai Company Information
- 4.10.2 Eisai Business Overview
- 4.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
- 4.10.5 Eisai Recent Developments
- 4.11 Kyowa Kirin Pharmaceuticals
- 4.11.1 Kyowa Kirin Pharmaceuticals Company Information
- 4.11.2 Kyowa Kirin Pharmaceuticals Business Overview
- 4.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
- 4.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
- 4.12 Hanmi Pharm
- 4.12.1 Hanmi Pharm Company Information
- 4.12.2 Hanmi Pharm Business Overview
- 4.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
- 4.12.5 Hanmi Pharm Recent Developments
5 Global Functional Dyspepsia Drug Market Scenario by Region
- 5.1 Global Functional Dyspepsia Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Functional Dyspepsia Drug Sales by Region: 2021-2032
- 5.2.1 Global Functional Dyspepsia Drug Sales by Region: 2021-2026
- 5.2.2 Global Functional Dyspepsia Drug Sales by Region: 2027-2032
- 5.3 Global Functional Dyspepsia Drug Revenue by Region: 2021-2032
- 5.3.1 Global Functional Dyspepsia Drug Revenue by Region: 2021-2026
- 5.3.2 Global Functional Dyspepsia Drug Revenue by Region: 2027-2032
- 5.4 North America Functional Dyspepsia Drug Market Facts & Figures by Country
- 5.4.1 North America Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Functional Dyspepsia Drug Sales by Country (2021-2032)
- 5.4.3 North America Functional Dyspepsia Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
- 5.5.1 Europe Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Functional Dyspepsia Drug Sales by Country (2021-2032)
- 5.5.3 Europe Functional Dyspepsia Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Functional Dyspepsia Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Functional Dyspepsia Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Functional Dyspepsia Drug Market Facts & Figures by Country
- 5.7.1 South America Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Functional Dyspepsia Drug Sales by Country (2021-2032)
- 5.7.3 South America Functional Dyspepsia Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Functional Dyspepsia Drug Sales by Type (2021-2032)
- 6.1.1 Global Functional Dyspepsia Drug Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Functional Dyspepsia Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Functional Dyspepsia Drug Revenue by Type (2021-2032)
- 6.2.1 Global Functional Dyspepsia Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Functional Dyspepsia Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Functional Dyspepsia Drug Sales by Application (2021-2032)
- 7.1.1 Global Functional Dyspepsia Drug Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Functional Dyspepsia Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Functional Dyspepsia Drug Revenue by Application (2021-2032)
- 7.2.1 Global Functional Dyspepsia Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Functional Dyspepsia Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Functional Dyspepsia Drug Value Chain Analysis
- 8.1.1 Functional Dyspepsia Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Functional Dyspepsia Drug Production Mode & Process
- 8.2 Functional Dyspepsia Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Functional Dyspepsia Drug Distributors
- 8.2.3 Functional Dyspepsia Drug Customers
9 Global Functional Dyspepsia Drug Analyzing Market Dynamics
- 9.1 Functional Dyspepsia Drug Industry Trends
- 9.2 Functional Dyspepsia Drug Industry Drivers
- 9.3 Functional Dyspepsia Drug Industry Opportunities and Challenges
- 9.4 Functional Dyspepsia Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst